DLD Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-420,000
Closed -$10M 205
2021
Q1
$10M Buy
+420,000
New +$7.81M 0.28% 46

DLD Asset Management's GNMK Position: Q2 2021 in Review

DLD Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 420,000 shares — an estimated $10M sold.

DLD Asset Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $10M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • DLD Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • DLD Asset Management sold 420,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $10M.
  • DLD Asset Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • DLD Asset Management's GenMark Diagnostics, Inc position peaked at $10M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on DLD Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.